Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirjam B Zeisel

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Plos One|May 25, 2013
A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmissionIsabel Fofana, Fei Xiao, Christine Thumann, et al.
Viruses|December 4, 2012
Neutralizing antibodies and pathogenesis of hepatitis C virus infectionSamira Fafi-Kremer, Catherine Fauvelle, Daniel J Felmlee, et al.
Plos Pathogens|July 10, 2010
Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factorsJulia Bitzegeio, Dorothea Bankwitz, Kathrin Hueging, et al.
Plos Pathogens|May 17, 2014
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agentsFei Xiao, Isabel Fofana, Laura Heydmann, et al.
Hepatology (Baltimore, Md.)|December 17, 2009
Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particlesWagane J A Benga, Sophie E Krieger, Maria Dimitrova, et al.
The Journal of Infectious Diseases|March 30, 2012
A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic virusesMarcel Krepstakies, Julie Lucifora, Claus-Henning Nagel, et al.
Gut|April 1, 2017
Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escapeChe C Colpitts, Rajiv G Tawar, Laurent Mailly, et al.
Journal of Innate Immunity|April 9, 2010
Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particlesMarco Hoffmann, Mirjam B Zeisel, Nikolaus Jilg, et al.
Plos One|July 11, 2013
Genotype 1 hepatitis C virus envelope features that determine antiviral response assessed through optimal covariance networksJohn M Murray, Rémy Moenne-Loccoz, Aurélie Velay, et al.
Hepatology (Baltimore, Md.)|March 23, 2013
Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alphaJoachim Lupberger, François H T Duong, Isabel Fofana, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Plos One|May 25, 2013
A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmissionIsabel Fofana, Fei Xiao, Christine Thumann, et al.
Viruses|December 4, 2012
Neutralizing antibodies and pathogenesis of hepatitis C virus infectionSamira Fafi-Kremer, Catherine Fauvelle, Daniel J Felmlee, et al.
Plos Pathogens|July 10, 2010
Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factorsJulia Bitzegeio, Dorothea Bankwitz, Kathrin Hueging, et al.
Plos Pathogens|May 17, 2014
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agentsFei Xiao, Isabel Fofana, Laura Heydmann, et al.
Hepatology (Baltimore, Md.)|December 17, 2009
Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particlesWagane J A Benga, Sophie E Krieger, Maria Dimitrova, et al.
The Journal of Infectious Diseases|March 30, 2012
A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic virusesMarcel Krepstakies, Julie Lucifora, Claus-Henning Nagel, et al.
Gut|April 1, 2017
Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escapeChe C Colpitts, Rajiv G Tawar, Laurent Mailly, et al.
Journal of Innate Immunity|April 9, 2010
Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particlesMarco Hoffmann, Mirjam B Zeisel, Nikolaus Jilg, et al.
Plos One|July 11, 2013
Genotype 1 hepatitis C virus envelope features that determine antiviral response assessed through optimal covariance networksJohn M Murray, Rémy Moenne-Loccoz, Aurélie Velay, et al.
Hepatology (Baltimore, Md.)|March 23, 2013
Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alphaJoachim Lupberger, François H T Duong, Isabel Fofana, et al.
Pageof 11